An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF

BACKGROUND Mycobacterium tuberculosis (MTB) is one of the most significant causes of mortality and morbidity. Early diagnose is important especially in multiple drug resistant tuberculosis to avoid transmission. Traditional techniques requires at least one to three weeks for diagnosis of tuberculosi...

Full description

Bibliographic Details
Main Authors: Yeliz Tanriverdi Cayci, Kemal Bilgin, Ahmet Yilmaz Coban, Asuman Birinci, Belma Durupınar
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ)
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762017001100756&lng=en&tlng=en
_version_ 1797721255463354368
author Yeliz Tanriverdi Cayci
Kemal Bilgin
Ahmet Yilmaz Coban
Asuman Birinci
Belma Durupınar
author_facet Yeliz Tanriverdi Cayci
Kemal Bilgin
Ahmet Yilmaz Coban
Asuman Birinci
Belma Durupınar
author_sort Yeliz Tanriverdi Cayci
collection DOAJ
description BACKGROUND Mycobacterium tuberculosis (MTB) is one of the most significant causes of mortality and morbidity. Early diagnose is important especially in multiple drug resistant tuberculosis to avoid transmission. Traditional techniques requires at least one to three weeks for diagnosis of tuberculosis. Diagnostic delays with multiple drug resistant tuberculosis are associated with worse clinical outcomes and increased transmission The Xpert MTB/RIF assay is one of the new diagnostic device for the diagnosis of tuberculosis and rapid detection of rifampicin resistance. OBJECTIVE We assessed the performance of Xpert MTB/RIF assay for detecting rifampicin resistance using phenotypic drug susceptibility tests as automated BD MGIT 960. METHODS Total of 2136 specimens were included in the study. Xpert MTB/RIF testing was performed on samples, using version 4 cartridges, according to the manufacturer's recommendations. The MTBC culture and first-line phenotypic DST were performed in automated BD MGIT 960 (Becton & Dickinson, USA) according to the recommendations of the manufacturer. Agar proportion was used in the case of inconsistency for rifampicin resistance. FINDINGS Thirty-four samples (19 respiratory and 15 nonrespiratory samples) were determined as positive for M. tuberculosis complex by Xpert MTB/RIF (Cepheid GeneXpert® System, USA). Xpert MTB/RIF assay detected 4/34 (11.7%) specimens as rifampicin resistant. One of the rifampicin resistant isolates was determined susceptible in MGIT 960 automated system. This isolate was also tested with agar proportion method and found susceptible to rifampicin. MAIN CONCLUSION The Xpert MTB/RIF assay can be used as first-line assay for the detection of M. tuberculosis. However, microbiologists must be aware of the limitations of the assay.
first_indexed 2024-03-12T09:30:57Z
format Article
id doaj.art-28abdfb7273d447ba240cfa0dd4f7570
institution Directory Open Access Journal
issn 1678-8060
language English
last_indexed 2024-03-12T09:30:57Z
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-28abdfb7273d447ba240cfa0dd4f75702023-09-02T13:54:10ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz1678-80601121175675910.1590/0074-02760170051S0074-02762017001100756An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIFYeliz Tanriverdi CayciKemal BilginAhmet Yilmaz CobanAsuman BirinciBelma DurupınarBACKGROUND Mycobacterium tuberculosis (MTB) is one of the most significant causes of mortality and morbidity. Early diagnose is important especially in multiple drug resistant tuberculosis to avoid transmission. Traditional techniques requires at least one to three weeks for diagnosis of tuberculosis. Diagnostic delays with multiple drug resistant tuberculosis are associated with worse clinical outcomes and increased transmission The Xpert MTB/RIF assay is one of the new diagnostic device for the diagnosis of tuberculosis and rapid detection of rifampicin resistance. OBJECTIVE We assessed the performance of Xpert MTB/RIF assay for detecting rifampicin resistance using phenotypic drug susceptibility tests as automated BD MGIT 960. METHODS Total of 2136 specimens were included in the study. Xpert MTB/RIF testing was performed on samples, using version 4 cartridges, according to the manufacturer's recommendations. The MTBC culture and first-line phenotypic DST were performed in automated BD MGIT 960 (Becton & Dickinson, USA) according to the recommendations of the manufacturer. Agar proportion was used in the case of inconsistency for rifampicin resistance. FINDINGS Thirty-four samples (19 respiratory and 15 nonrespiratory samples) were determined as positive for M. tuberculosis complex by Xpert MTB/RIF (Cepheid GeneXpert® System, USA). Xpert MTB/RIF assay detected 4/34 (11.7%) specimens as rifampicin resistant. One of the rifampicin resistant isolates was determined susceptible in MGIT 960 automated system. This isolate was also tested with agar proportion method and found susceptible to rifampicin. MAIN CONCLUSION The Xpert MTB/RIF assay can be used as first-line assay for the detection of M. tuberculosis. However, microbiologists must be aware of the limitations of the assay.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762017001100756&lng=en&tlng=enMycobacterium tuberculosisrifampicin resistanceXpert MTB/RIF assay
spellingShingle Yeliz Tanriverdi Cayci
Kemal Bilgin
Ahmet Yilmaz Coban
Asuman Birinci
Belma Durupınar
An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
Memorias do Instituto Oswaldo Cruz
Mycobacterium tuberculosis
rifampicin resistance
Xpert MTB/RIF assay
title An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
title_full An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
title_fullStr An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
title_full_unstemmed An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
title_short An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
title_sort evaluation of false positive rifampicin resistance on the xpert mtb rif
topic Mycobacterium tuberculosis
rifampicin resistance
Xpert MTB/RIF assay
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762017001100756&lng=en&tlng=en
work_keys_str_mv AT yeliztanriverdicayci anevaluationoffalsepositiverifampicinresistanceonthexpertmtbrif
AT kemalbilgin anevaluationoffalsepositiverifampicinresistanceonthexpertmtbrif
AT ahmetyilmazcoban anevaluationoffalsepositiverifampicinresistanceonthexpertmtbrif
AT asumanbirinci anevaluationoffalsepositiverifampicinresistanceonthexpertmtbrif
AT belmadurupınar anevaluationoffalsepositiverifampicinresistanceonthexpertmtbrif
AT yeliztanriverdicayci evaluationoffalsepositiverifampicinresistanceonthexpertmtbrif
AT kemalbilgin evaluationoffalsepositiverifampicinresistanceonthexpertmtbrif
AT ahmetyilmazcoban evaluationoffalsepositiverifampicinresistanceonthexpertmtbrif
AT asumanbirinci evaluationoffalsepositiverifampicinresistanceonthexpertmtbrif
AT belmadurupınar evaluationoffalsepositiverifampicinresistanceonthexpertmtbrif